Ledger.Open graph →
SEC Form D · filed July 14, 2020

Goldfinch Bio, Inc

Offering
Sold
$69.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Lori Rudolph-Owen · CAMBRIDGE, MAExecKyle Kuvalanka · CAMBRIDGE, MAExecAbbie Celniker · Boston, MADirectorJoy Ghosh · New Jersey, NJDirectorAnthony Johnson · Chapel Hill, NCExec · DirectorNeil Exter · New York, NYDirectorWen Chen · CAMBRIDGE, MADirectorFrank Czerwiec · CAMBRIDGE, MAExecCurtis Demick · CAMBRIDGE, MAExecJean-Christophe Harmange · CAMBRIDGE, MAExecLouis Brenner · Newton, MADirectorFrank Maddux · CAMBRIDGE, MADirectorAbbie Celniker · Boston, MADirectorJoy Ghosh · CAMBRIDGE, MADirectorAnthony Johnson · Buffalo, NYExec · DirectorNeil Exter · Boston, MADirectorWen Chen · CAMBRIDGE, MADirectorFrank Czerwiec · CAMBRIDGE, MAExecLori Rudolph-Owen · CAMBRIDGE, MAExecKyle Kuvalanka · CAMBRIDGE, MAExecCurtis Demick · CAMBRIDGE, MAExecJean-Christophe Harmange · CAMBRIDGE, MAExecLouis Brenner · Newton, MADirectorFrank Maddux · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗